Group One Trading’s PharmaCyte Biotech PMCB Stock Holding History
Bought
Maintained
Sold
Other funds holding PMCB
Group One Trading's PMCB Position: Q3 2026 in Review
Group One Trading sold out of PharmaCyte Biotech (PMCB) in Q3 2026, closing a stake of 26 shares — an estimated $385 sold.
Group One Trading first reported a position in PMCB in Q2 2022 and held it in 6 quarters. The position peaked at $180K in Q3 2022. 20 funds tracked by Wall St. Rank hold PMCB as of Q3 2026.
- Group One Trading reported no remaining PharmaCyte Biotech position as of Q3 2026 after selling out during the quarter.
- Group One Trading sold 26 PharmaCyte Biotech shares in Q3 2026, an estimated $385.
- Group One Trading first reported a position in PharmaCyte Biotech in Q2 2022 and held it in 6 quarters.
- Group One Trading's PharmaCyte Biotech position peaked at $180K in Q3 2022.
- 20 funds tracked by Wall St. Rank held PharmaCyte Biotech as of Q3 2026.
Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.